Clare Buckeridge

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Pulmonary Arterial Hypertension

Placebo Controlled

Protein Protein

Top Venues

Diabetes, obesity & metabolism

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Clare Buckeridge, Nikolaos Tsamandouras, Santos Carvajal-Gonzalez, Lisa S Brown, Martha Hernandez-Illas, Aditi R Saxena
Once-daily oral small-molecule glucagon-like peptide-1 receptor agonist lotiglipron (PF-07081532) for type 2 diabetes and obesity: Two randomized, placebo-controlled, multiple-ascending-dose Phase 1 studies. Diabetes, obesity & metabolism 26 (8) (2024)
Clare Buckeridge, Nikolaos Tsamandouras, Santos Carvajal-Gonzalez, Lisa S Brown, Martha Hernandez-Illas, Aditi R Saxena
Once-daily oral small-molecule glucagon-like peptide-1 receptor agonist lotiglipron (PF-07081532) for type 2 diabetes and obesity: Two randomized, placebo-controlled, multiple-ascending-dose Phase 1 studies. Diabetes, obesity & metabolism (2024)
Jeffrey Crawford, Roberto A Calle, Susie M Collins, Yan Weng, Shannon L Lubaczewski, Clare Buckeridge, Ellen Q Wang, Magdalena A Harrington, Anil Tarachandani, Michelle I Rossulek, James H Revkin
A Phase 1b First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)